Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,56
KB1,28
PKN141,96142,260,37
Msft442,76442,83,69
Nokia12,48512,975-6,54
IBM288,59288,939,22
Mercedes-Benz Group AG52,152,19-0,99
PFE26,0326,04-0,40
29.05.2026 18:24:59
Indexy online
AD Index online
select
AD Index online
 

  • 29.05.2026 17:48:14
EDAP TMS SA Depository Receipt (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
4,37 3,93 0,17 115 610
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 29.05.2026
Popis společnosti
Obecné informace
Název společnostiEdap Tms SA (ADR)
TickerEDAP
Kmenové akcie:ADR
RICEDAP.O
ISIN-
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.03.2026
Počet zaměstnanců k 31.12.2025 289
Akcie v oběhu k 31.03.2026 37 481 986
MěnaUSD
Kontaktní informace
UliceParc Activite
MěstoVAULX-EN-VELIN
PSČ69120
ZeměFrance
Kontatní osobaBlandine Confort
Funkce kontaktní osobyInvestor Relations Officer, Director - Legal Affairs
Telefon33 472 153 150
Fax33472153151
Kontatní telefon33 472 153 150

Business Summary: Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Financial Summary: BRIEF: For the three months ended 31 March 2026, Edap Tms SA (ADR) revenues increased 25% to $17.8M. Net loss increased 22% to $9.1M. Revenues reflect High Intensity Focused Ultrasound Division segment increase of 78% to $11.6M. Higher net loss reflects Reconciling items segment loss increase from $975K to $2M, High Intensity Focused Ultrasound Division segment loss increase of 5% to $5.9M, ESWL Division segment income decrease of 40% to $322K.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSSurgical and Medical Instrument Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007Electromedical Apparatus Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICElectromedical Equipment
SICElectromedical Equipment
SICMedical And Hospital Equipment
SICSurgical And Medical Instruments
SICHolding Companies, Nec



  • Poslední aktualizace: 29.05.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Interim Independent Chairman of the BoardLance Willsey6330.09.202430.09.2024
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed IncRyan Rhodes6323.08.202312.06.2021
Chief Financial OfficerKenneth Mobeck5401.01.202401.01.2024
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)Jean-Francois Bachelard6101.01.1999
President of EDAP TMS France SASFrederic Pech5601.05.2023
Chief Accounting OfficerFrancois Dietsch4901.01.202414.07.2015
Investor Relations Officer, Director - Legal AffairsBlandine Confort-
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbHAlex Fromm-
General Manager of EDAP TMS KoreaJeon Jon-hyeon-
General Manager of EDAP Technomed (M) Sdn, BhdHerve De Soultrait-